These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

86 related items for PubMed ID: 18417980

  • 1. Human placental growth hormone is increased in maternal serum in pregnancies affected by Down syndrome.
    Papadopoulou E, Sifakis S, Giahnakis E, Fragouli Y, Karkavitsas N, Koumantakis E, Kalmanti M.
    Fetal Diagn Ther; 2008; 23(3):211-6. PubMed ID: 18417980
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Placental growth hormone in Down's syndrome screening.
    Baviera G, Carbone C, Corrado F, Mastrantonio P.
    J Matern Fetal Neonatal Med; 2004 Oct; 16(4):241-3. PubMed ID: 15590454
    [Abstract] [Full Text] [Related]

  • 5. Maternal serum prostate-specific antigen and Down syndrome in the first and second trimesters of pregnancy. International Prenatal Screening Research Group.
    Wald NJ, Hackshaw AK, Diamandis EP, Melegos DN.
    Prenat Diagn; 1999 Jul; 19(7):674-6. PubMed ID: 10419619
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Placental growth hormone and growth hormone binding protein are first trimester maternal serum markers of Down syndrome.
    Christiansen M.
    Prenat Diagn; 2009 Dec; 29(13):1249-55. PubMed ID: 19844941
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Maternal plasma levels of follistatin-related gene protein in the first trimester of pregnancies with Down syndrome.
    Miron P, Lambert J, Marcil A, Cowans NJ, Stamatopoulou A, Spencer K.
    Prenat Diagn; 2010 Mar; 30(3):224-8. PubMed ID: 20063262
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Down syndrome maternal serum marker screening after 18 weeks' gestation.
    Muller F, Dreux S, Oury JF, Luton D, Uzan S, Uzan M, Levardon M, Dommergues M.
    Prenat Diagn; 2002 Nov; 22(11):1001-4. PubMed ID: 12424764
    [Abstract] [Full Text] [Related]

  • 13. Maternal serum placental growth hormone and insulinlike growth factor binding proteins 1 and 3 in pregnancies affected by fetal aneuploidy and other abnormalities: implications for prenatal diagnosis of trisomy 21.
    Moghadam S, Engel W, Bougoussa M, Hennen G, Igout A, Sancken U.
    Fetal Diagn Ther; 1998 Nov; 13(5):291-7. PubMed ID: 9813422
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Adverse pregnancy outcomes after a false-positive second trimester serum screen for Down syndrome in Thai pregnant women.
    Sritippayawan S, Vachirasrisoontra C.
    J Med Assoc Thai; 2005 Apr; 88(4):449-54. PubMed ID: 16146246
    [Abstract] [Full Text] [Related]

  • 20. Second-trimester maternal serum CA-125 versus estriol in the multiple-marker screening test for Down syndrome.
    Wenstrom KD, Owen J, Boots L.
    Obstet Gynecol; 1997 Mar; 89(3):359-63. PubMed ID: 9052585
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.